文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.

作者信息

Miao Deyu, Jiang Mengyin, Liu Zhongyang, Gu Guangzhi, Hu Quanyin, Kang Ting, Song Qingxiang, Yao Lei, Li Wei, Gao Xiaoling, Sun Mingjiang, Chen Jun

机构信息

Laboratory of Smart Drug Delivery, Ministry of Education & PLA, School of Pharmacy, Fudan University , 826 Zhangheng Road, Shanghai, 201203, P. R. China.

出版信息

Mol Pharm. 2014 Jan 6;11(1):90-101. doi: 10.1021/mp400189j. Epub 2013 Dec 2.


DOI:10.1021/mp400189j
PMID:24295590
Abstract

Chemotherapy is an indispensable auxiliary treatment for glioma but highly limited by the existence of both blood-brain barrier (BBB) and blood-brain tumor barrier (BBTB). The dysfunctional brain tumor blood vessels and high interstitial pressure in glioma also greatly hindered the accumulation and deep penetration of chemotherapeutics into the glioma. Lactoferrin (Lf), with its receptor overexpressed on both the brain endothelial cells and glioma cells, was here functionalized to the surface of poly(ethylene glycol)-poly(lactic acid) nanoparticles to mediate BBB/BBTB and glioma cell dual targeting. tLyP-1, a tumor-homing peptide, which contains a C-end Rule sequence that can mediate tissue penetration through the neuropilin-1-dependent internalization pathway, was coadministrated with Lf-functionalized nanoparticles (Lf-NP) to enhance its accumulation and deep penetration into the glioma parenchyma. Enhanced cellular association in both BCEC and C6 cells, increased cytotoxicity of the loaded paclitaxel, and deep penetration in the 3D glioma spheroids was achieved by Lf-NP. Following coadministration with tLyP-1, the functionalized nanoparticles obtained improved tumor targeting, glioma vascular extravasation, and antiglioma efficacy. The findings here suggested that the strategy by coadministrating BBB/BBTB and glioma cells dual-targeting nanocarriers with a tumor penetration enhancement peptide represent a promising platform for antiglioma drug delivery.

摘要

相似文献

[1]
Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.

Mol Pharm. 2014-1-6

[2]
F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.

Biomaterials. 2012-11-10

[3]
Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel.

Biomaterials. 2013-4-29

[4]
Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.

Mol Pharm. 2015-8-3

[5]
Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.

Biomaterials. 2016-5-24

[6]
LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.

Biomaterials. 2013-9-3

[7]
Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.

Mol Pharm. 2014-6-2

[8]
Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.

Biomaterials. 2012-8-11

[9]
Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.

Int J Pharm. 2018-10-12

[10]
Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.

Biomaterials. 2011-3-21

引用本文的文献

[1]
Beyond the Walls of Troy: A Scoping Review on Pharmacological Strategies to Enhance Drug Delivery Across the Blood-Brain Barrier and Blood-Tumor Barrier.

Int J Mol Sci. 2025-7-22

[2]
Nano-formulations in disease therapy: designs, advances, challenges, and future directions.

J Nanobiotechnology. 2025-5-30

[3]
Ultrasmall solid lipid nanoparticles as a potential innovative delivery system for a drug combination against glioma.

Nanomedicine (Lond). 2025-1

[4]
Next-generation agents for fluorescence-guided glioblastoma surgery.

Bioeng Transl Med. 2023-10-11

[5]
Targeted Ferroptosis-Immunotherapy Synergy: Enhanced Antiglioma Efficacy with Hybrid Nanovesicles Comprising NK Cell-Derived Exosomes and RSL3-Loaded Liposomes.

ACS Appl Mater Interfaces. 2024-6-5

[6]
Functionalized nanoparticles crossing the brain-blood barrier to target glioma cells.

PeerJ. 2023

[7]
Lactoferrin and Nanotechnology: The Potential for Cancer Treatment.

Pharmaceutics. 2023-4-28

[8]
Polymersome-based protein drug delivery - quo vadis?

Chem Soc Rev. 2023-1-25

[9]
Tumor microenvironment penetrating chitosan nanoparticles for elimination of cancer relapse and minimal residual disease.

Front Oncol. 2022-11-30

[10]
Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges.

Mol Pharm. 2022-11-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索